Trials / Enrolling By Invitation
Enrolling By InvitationNCT06811740
Treatable Traits of Severe Asthma
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Severe or uncontrolled asthma is a complex heterogeneous disease, in which patients may exhibit different types of airway inflammation and often accompany multiple comorbidities and risk factors. Identifying potential modifiable factors that influence prognosis, i.e., "treatable traits," and targeting these traits for individualized, bundled management of patients may help improve the quality of life of asthma patients and enhance asthma control levels. This project aims to investigate the distribution of treatable traits in uncontrolled asthma patients in Beijing by conducting pulmonary function tests, exhaled nitric oxide tests, blood tests, allergen IgE tests, and chest CT scans, as well as detailed questionnaires, on patients from three tertiary hospitals in Beijing. The project will also assess the impact of treatable traits on the quality of life or asthma control levels of uncontrolled asthma patients in a multidimensional manner. Furthermore, the project will select severe asthma patients and establish an individualized, bundled management model based on the treatable traits of severe asthma, through multidisciplinary consultations and shared decision-making with patients. A randomized, parallel-group clinical trial will then be conducted for six months to confirm whether this management model is superior to conventional management in improving the quality of life or asthma control levels of severe asthma patients. The implementation of this project will establish a new model of individualized management for severe asthma based on treatable traits, thereby improving the management level of severe asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Individualized cluster management | Individualized cluster management for treatable traits |
| PROCEDURE | Routine asthma treatment | Routine asthma treatment according to current guidelines |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-02-06
- Last updated
- 2025-02-18
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06811740. Inclusion in this directory is not an endorsement.